Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29659675 | 1.00 | HTT (0.46) | HTTABCB11ESR1PGRCHRM2 | |
| Bromide SCHEMBL384486 | 0.98 | KDM4E (0.46) | HTTCHRM2ADRA2AADORA3CHRM1 | |
| Hydrochloric Acid SCHEMBL2833307 | 0.98 | RAD52 (0.46) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL4070618 | 0.94 | HTT (0.53) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL22265223 | 0.93 | HTT (0.41) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL29851032 | 0.93 | HTT (0.41) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL385303 | 0.93 | HTT (0.41) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL3922589 | 0.93 | HTT (0.56) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL5292793 | 0.93 | HTT (0.56) | HTTABCB11ESR1PGRCHRM2 | |
| SCHEMBL5291635 | 0.93 | HTT (0.56) | HTTABCB11ESR1PGRCHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812382-B1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF SE (DE) | 2013-01-23 | — | — | EP | claimed |
| WO-2012130803-A1 | METHOD FOR SEPARATING OFF HALOGENS FROM MIXTURES OF MATTER | BAYER TECHNOLOGY SERVICES GMBH (DE) | 2012-10-04 | — | — | WO | claimed |
| JP-4794561-B2 | — | — | 2011-10-19 | — | — | JP | claimed |
| WO-2010125302-A1 | USE OF IONIC LIQUID FOR THE PERMANENT SHAPING OF KERATINIC FIBRES | L'OREAL (FR) | 2010-11-04 | — | — | WO | claimed |
| CN-1962602-B | Process for preparing dimethyl carbonate by reacting methanol, carbon monoxide and oxygen | UNIV SHANXI NORMAL | 2010-05-12 | — | — | CN | claimed |
| US-7659430-B2 | Method for separating hydrogen chloride and phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2010-02-09 | — | — | US | claimed |
| EP-1789160-B1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESSELLSCHAFT (DE) | 2009-04-30 | — | — | US | claimed |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-20 | — | — | US | claimed |
| EP-1812382-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| EP-1789160-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2007-05-30 | — | — | EP | claimed |
| CN-1962602-A | Process for preparing dimethyl carbonate by reacting methanol, carbon monoxide and oxygen | UNIV SHANXI NORMAL (CN) | 2007-05-16 | — | — | CN | claimed |
| WO-2007006418-A1 | IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | claimed |
| WO-2006048171-A1 | METHOD FOR PRODUCING POLYISOCYANATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | claimed |
| WO-2006029788-A1 | METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-23 | — | — | WO | claimed |
| WO-2024142789-A1 | GOLD ELECTROPLATING SOLUTION AND METHOD FOR PRODUCING GOLD-ELECTROPLATED COATING | 日本高純度化学株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-20240034633-A1 | PROCESS FOR PRODUCING PHOSGENE BY REACTION OF POLYCHLORINE ANIONS AND CARBON MONOXIDE | COVESTRO DEUTSCHLAND AG (DE) | 2024-02-01 | — | — | US | disclosed |
| US-20050269001-A1 | Ionic liquid energetic materials | AMERICAN PACIFIC CORPORATION | 2005-12-08 | — | — | US | disclosed |
| WO-2005111151-A1 | SECONDARY TREATMENT OF PIGMENTS IN IONIC LIQUIDS | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2005-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090112017-A1 | METHOD FOR PRODUCING POLYISOCYANATES | PGLS, INMT, PNMT | HTT 1805/4885ABCB11 1527/4885ESR1 3985/4885 |
| US-20070293707-A1 | Method for Separating Hydrogen Chloride and Phosgene | PSPH, SLC9B2, HVCN1 | HTT 569/4885ABCB11 927/4885ESR1 3687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.